India Glycols Shares Drop 79% on Ex-Demerger Adjustment—Not a Real Crash

The Quick Take

• India Glycols shares fell to Rs 241.30 on BSE, showing an apparent 79.35% drop—but the decline is a technical ex-demerger price adjustment, not a real loss of investor wealth
• The company split into three separately listed entities from September 1, 2026: India Glycols (chemicals), IGL Spirits Ltd (spirits), and Ennature Bio Pharma Ltd (bioethanol/pharma)
• Once markets absorbed the demerger structure, the adjusted India Glycols shares gained approximately 5%, confirming shareholder value remains intact across all three counters

India Glycols shares triggered panic across trading apps on Wednesday when they opened at Rs 229.85, displaying a near-80% decline from the prior session close of Rs 1,112.90. The apparent collapse is a mechanical artifact of the company completing its three-way demerger effective September 1, 2026—not a genuine erosion of investor wealth. Stock exchanges recalibrate the base price to reflect only the retained chemicals entity when a demerger takes effect, causing raw percentage comparisons to look catastrophic in apps that compare today's open to yesterday's pre-split close. Shareholders who held India Glycols before the record date retain proportional stakes in all three new entities.

The restructuring carved India Glycols into three independently listed companies: the residual India Glycols, which continues the ethylene glycol, industrial solvents, and specialty chemicals operations; IGL Spirits Ltd, housing the potable alcohol and spirits business; and Ennature Bio Pharma Ltd, which holds the bioethanol and pharmaceutical-grade ingredients segment. Each entity now pursues its own capital-raising strategy and attracts sector-specific institutional investors rather than trading at a conglomerate discount. With a market capitalisation of approximately Rs 1,617 crore, the core India Glycols chemicals business serves industries spanning pharmaceuticals, textiles, and industrial manufacturing.

By midday, India Glycols had recovered from its ex-demerger open of Rs 229.85 to trade at Rs 241.30, representing roughly a 5% gain on an adjusted basis—a signal that equity markets are pricing the standalone chemicals business on its own operational merits. Analysts watching post-demerger splits note that price discovery across all three entities typically requires several trading sessions as liquidity builds on each counter and institutional investors rebalance portfolios to match their sector mandates. Retail investors who see the 79% figure on trading apps should check whether their platform has applied the demerger adjustment before interpreting the percentage change as a loss.

Synthesized from 2 sources.